The U.S. Food and Drug Administration (FDA) announced on September 13, 2019 that it is investigating Zantac cancer risks after testing of Zantac 150 tablets found the commonly-used heartburn medication contains a carcinogenic chemical up to 3,000 times greater than the FDA’s daily intake limit. The carcinogenic chemical present in Zantac is known as N-nitrosodimethylamine (“NDMA”). We believe manufacturers of Zantac had knowledge that this dangerous compound was present in Zantac but failed to act promptly and responsibly. As such, we are litigating cases against the manufacturers responsible and asserting various product liability claims against them on behalf of victims of cancer.
The Miller Firm has aggressively pursued cases for victims of cancer including litigating multiple trials in the Roundup Non-Hodgkin’s Lymphoma and Actos Bladder Cancer litigations. At this time, we are pursuing cases for people that ingested the drug Zantac for over 3 months and were subsequently diagnosed with one of the following cancers:
- Bladder cancer
- Colon and rectal cancer
- Esophageal cancer
- Intestinal cancer
- Kidney cancer
- Liver cancer
- Ovarian cancer
- Pancreatic cancer
- Prostate cancer
- Stomach cancer
- Thyroid cancer
- Uterine cancer
If you have ingested Zantac and been diagnosed with one of the above cancers, please call the Miller Firm today for a free consultation at 1-800-882-2525 or email us at [email protected]. Our lawyers have the ability to represent clients across the country against the manufacturers of this drug and would pursue your case as an individual lawsuit if it meets our qualifying criteria.